China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
18.86
+0.01 (0.05%)
Mar 30, 2026, 12:14 PM CST

SHE:300294 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
112.7396.99237.47432.2344.53
Depreciation & Amortization
147.98102.9898.5797.0399.35
Other Amortization
16.7613.9815.3913.7413.63
Loss (Gain) From Sale of Assets
-5.10.61-1.3-0.070.87
Asset Writedown & Restructuring Costs
309.683.8326.7253.6580.57
Loss (Gain) From Sale of Investments
-59.98-65.58-99.75-43.84-43.11
Provision & Write-off of Bad Debts
21.518.792.372.80.05
Other Operating Activities
-28-16.5914.4613.9231.26
Change in Accounts Receivable
-471.72-211.4940.02-11.73799.83
Change in Inventory
-12.6-120.06107.011.2811.77
Change in Accounts Payable
102.14116.59-92.3256.244.14
Change in Unearned Revenue
5.88-4.01-3.57-4.13-1.46
Change in Other Net Operating Assets
---3.2811.59
Operating Cash Flow
61.16299.78641.73596.441,345
Operating Cash Flow Growth
-79.60%-53.29%7.59%-55.67%87.23%
Capital Expenditures
-535.31-197.79-87.5-138.41-68.12
Sale of Property, Plant & Equipment
3.061.823.260.334.41
Cash Acquisitions
--1,778---
Divestitures
193.79239.61269--
Investment in Securities
-397.98975.51-248.85-500-2,505
Other Investing Activities
55.52111.2678.3377.8632.4
Investing Cash Flow
-680.91-647.5314.25-560.22-2,536
Long-Term Debt Issued
47.04-22.15-251.85
Long-Term Debt Repaid
-5.87-76.3-24.98-3.82-563.55
Net Debt Issued (Repaid)
41.17-76.3-2.83-3.82-311.7
Issuance of Common Stock
----2,400
Common Dividends Paid
-156.4-232.41-100.85-83.19-46.03
Other Financing Activities
-39.845.24-132.972-9.64
Financing Cash Flow
-155.07-303.47-236.65-85.012,032
Foreign Exchange Rate Adjustments
-0.13----
Net Cash Flow
-774.96-651.23419.33-48.79841.39
Free Cash Flow
-474.15101.99554.23458.031,277
Free Cash Flow Growth
--81.60%21.00%-64.14%121.72%
Free Cash Flow Margin
-23.03%5.88%20.90%16.60%48.19%
Free Cash Flow Per Share
-0.930.201.100.912.93
Cash Income Tax Paid
183.18167.06250.39227.94192.85
Levered Free Cash Flow
-361.3216.4376.4354.851,141
Unlevered Free Cash Flow
-360.616.82376.68355.241,148
Change in Working Capital
-454.32-225.247.7927.01818.22
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.